Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens C Eickhoff

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2019
Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate CancerDouglas G McNeel, Jens C Eickhoff, Laura E Johnson, et al.
American Journal of Cancer Research|January 26, 2016
Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastomaRoberta Marino, Dana C Baiu, Saswati Bhattacharya, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2011
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinomaJoshua M Lang, Mahazarin R Kaikobad, Marianne Wallace, et al.
Journal of Hypertension|September 9, 2024
Using an in-office passive leg raise to identify older adults with suboptimal blood pressure controlJeremy R Williams, Molly A Cole, Ryan J Pewowaruk, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|April 20, 2026
Effect modification of late surfactant treatment by patent ductus arteriosus status in ventilated preterm infants: a secondary analysis of a randomized clinical trialPatrick J Peebles, Jens C Eickhoff, Timothy G Elgin, et al.
Clinical Genitourinary Cancer|July 10, 2013
A randomized phase II trial evaluating different schedules of zoledronic acid on bone mineral density in patients with prostate cancer beginning androgen deprivation therapyJoshua M Lang, Marianne Wallace, Jordan T Becker, et al.
Lung Cancer (Amsterdam, Netherlands)|August 15, 2008
Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancerAnne M Traynor, Joan H Schiller, Laura P Stabile, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2010
The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumorsBrian S Choi, Dona B Alberti, William R Schelman, et al.
Hospital Pediatrics|March 11, 2021
Evaluation and Improvement of Intern Progress Note Assessments and PlansMichelle M Kelly, Daniel J Sklansky, Kirstin A M Nackers, et al.
Leukemia & Lymphoma|August 26, 2011
Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology NetworkVaishalee P Kenkre, Walter L Long, Jens C Eickhoff, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2019
Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate CancerDouglas G McNeel, Jens C Eickhoff, Laura E Johnson, et al.
American Journal of Cancer Research|January 26, 2016
Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastomaRoberta Marino, Dana C Baiu, Saswati Bhattacharya, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2011
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinomaJoshua M Lang, Mahazarin R Kaikobad, Marianne Wallace, et al.
Journal of Hypertension|September 9, 2024
Using an in-office passive leg raise to identify older adults with suboptimal blood pressure controlJeremy R Williams, Molly A Cole, Ryan J Pewowaruk, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|April 20, 2026
Effect modification of late surfactant treatment by patent ductus arteriosus status in ventilated preterm infants: a secondary analysis of a randomized clinical trialPatrick J Peebles, Jens C Eickhoff, Timothy G Elgin, et al.
Clinical Genitourinary Cancer|July 10, 2013
A randomized phase II trial evaluating different schedules of zoledronic acid on bone mineral density in patients with prostate cancer beginning androgen deprivation therapyJoshua M Lang, Marianne Wallace, Jordan T Becker, et al.
Lung Cancer (Amsterdam, Netherlands)|August 15, 2008
Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancerAnne M Traynor, Joan H Schiller, Laura P Stabile, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2010
The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumorsBrian S Choi, Dona B Alberti, William R Schelman, et al.
Hospital Pediatrics|March 11, 2021
Evaluation and Improvement of Intern Progress Note Assessments and PlansMichelle M Kelly, Daniel J Sklansky, Kirstin A M Nackers, et al.
Leukemia & Lymphoma|August 26, 2011
Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology NetworkVaishalee P Kenkre, Walter L Long, Jens C Eickhoff, et al.
Pageof 18